Experimental porphyric neuropathy: a preliminary report

Area of Science:

• Neuroscience
• Toxicology
• Biochemistry

Background:

• Porphyric neuropathy is a debilitating neurological disorder.
• Porphyrins are compounds involved in heme synthesis, and some can be neurotoxic.
• Hematoporphyrin derivative (HpD) and tetraphenyl-porphinesulfonate (TPPS) are used in photodynamic therapy.

Purpose of the Study:

• To develop and characterize an experimental model for studying porphyric neuropathy.
• To compare the neurotoxic effects of TPPS, HpD, and delta-amino-levulinic acid (ALA) in mice.
• To investigate the reversibility of induced nerve dysfunction and associated structural changes.

Main Methods:

• Mice were injected with TPPS, HpD, or ALA.
• Motor nerve conduction velocity (MNCV) was measured to assess nerve function.
• Ultrastructural examination of motor nerves was performed at various time points post-injection.

Main Results:

• TPPS, HpD, and ALA injections significantly decreased MNCV in mice.
• Nerve function recovered within 1-3 weeks after ALA or HpD administration.
• TPPS induced persistent MNCV reduction and progressive nerve structural abnormalities without recovery within 50 days.
• ALA and HpD did not cause observable nerve abnormalities upon ultrastructural examination.

Conclusions:

• TPPS exhibits significant and persistent neurotoxicity in mice, unlike ALA and HpD.
• The experimental model effectively demonstrates dose-dependent and structural nerve damage induced by TPPS.
• Caution is advised regarding the use of TPPS as a photosensitizer in human cancer treatment due to its neurotoxic potential.